Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination of rituximab with chlorambucil as first line treatment in patients with mantle cell lymphoma: a highly effective regimen.
Sachanas S, Pangalis GA, Vassilakopoulos TP, Korkolopoulou P, Kontopidou FN, Athanasoulia M, Yiakoumis X, Kalpadakis C, Georgiou G, Masouridis S, Moschogiannis M, Tsirkinidis P, Pappis V, Kokoris SI, Siakantaris MP, Panayiotidis P, Angelopoulou MK. Sachanas S, et al. Among authors: pangalis ga. Leuk Lymphoma. 2011 Mar;52(3):387-93. doi: 10.3109/10428194.2010.534518. Epub 2010 Dec 6. Leuk Lymphoma. 2011. PMID: 21133713 Clinical Trial.
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care.
Vassilakopoulos TP, Pangalis GA, Katsigiannis A, Papageorgiou SG, Constantinou N, Terpos E, Zorbala A, Vrakidou E, Repoussis P, Poziopoulos C, Galani Z, Dimopoulou MN, Kokoris SI, Sachanas S, Kalpadakis C, Dimitriadou EM, Siakantaris MP, Kyrtsonis MC, Dervenoulas J, Dimopoulos MA, Meletis J, Roussou P, Panayiotidis P, Beris P, Angelopoulou MK. Vassilakopoulos TP, et al. Among authors: pangalis ga. Oncologist. 2012;17(2):239-49. doi: 10.1634/theoncologist.2011-0275. Epub 2012 Jan 26. Oncologist. 2012. PMID: 22282906 Free PMC article.
Rituximab monotherapy is highly effective in splenic marginal zone lymphoma.
Kalpadakis C, Pangalis GA, Dimopoulou MN, Vassilakopoulos TP, Kyrtsonis MC, Korkolopoulou P, Kontopidou FN, Siakantaris MP, Dimitriadou EM, Kokoris SI, Tsaftaridis P, Plata E, Angelopoulou MK. Kalpadakis C, et al. Among authors: pangalis ga. Hematol Oncol. 2007 Sep;25(3):127-31. doi: 10.1002/hon.820. Hematol Oncol. 2007. PMID: 17514771
Rituximab in the treatment of EBV-positive low grade B-cell lymphoma.
Diamantopoulos PT, Polonyfi K, Sofotasiou M, Papadopoulou V, Kalala F, Iliakis T, Zervakis K, Tsilimidos G, Kouzis P, Kyrtsonis MC, Vassilakopoulos T, Angelopoulou M, Siakantaris M, Vayopoulos G, Kollia P, Pangalis G, Viniou NA. Diamantopoulos PT, et al. Anticancer Res. 2013 Dec;33(12):5693-8. Anticancer Res. 2013. PMID: 24324119
Treatment of splenic marginal zone lymphoma with rituximab monotherapy: progress report and comparison with splenectomy.
Kalpadakis C, Pangalis GA, Angelopoulou MK, Sachanas S, Kontopidou FN, Yiakoumis X, Kokoris SI, Dimitriadou EM, Dimopoulou MN, Moschogiannis M, Korkolopoulou P, Kyrtsonis MC, Siakantaris MP, Papadaki T, Tsaftaridis P, Plata E, Papadaki HE, Vassilakopoulos TP. Kalpadakis C, et al. Among authors: pangalis ga. Oncologist. 2013;18(2):190-7. doi: 10.1634/theoncologist.2012-0251. Epub 2013 Jan 23. Oncologist. 2013. PMID: 23345547 Free PMC article.
Central nervous system involvement in primary bone marrow or splenic marginal zone lymphoma: Report of two cases and review of the literature.
Angelopoulou MK, Vassilakopoulos TP, Konstantinou E, Boutsikas G, Asimakopoulos JV, Triantafyllou EF, Petevi K, Kanellopoulos A, Moschogiannis M, Pangalis GA, Siakantaris MP, Konstantopoulos K. Angelopoulou MK, et al. Among authors: pangalis ga. Hematol Oncol. 2019 Apr;37(2):219-222. doi: 10.1002/hon.2571. Epub 2019 Feb 1. Hematol Oncol. 2019. PMID: 30592785 Review. No abstract available.
Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies.
Vassilakopoulos TP, Papageorgiou SG, Angelopoulou MK, Chatziioannou S, Prassopoulos V, Karakatsanis S, Arapaki M, Mellios Z, Sachanas S, Kalpadakis C, Katodritou E, Leonidopoulou T, Kotsianidis I, Hatzimichael E, Kotsopoulou M, Dimou M, Variamis E, Boutsis D, Terpos E, Michali E, Karianakis G, Tsirkinidis P, Vadikolia C, Poziopoulos C, Pigaditou A, Vrakidou E, Siakantaris MP, Kyrtsonis MC, Symeonidis A, Anargyrou K, Papaioannou M, Chatziharissi E, Vervessou E, Tsirogianni M, Palassopoulou M, Gainaru G, Mainta C, Tsirigotis P, Assimakopoulou T, Konstantinidou P, Papadaki H, Dimopoulos MA, Pappa V, Karmiris T, Roussou P, Datseris I, Panayiotidis P, Konstantopoulos K, Pangalis GA, Rondogianni P. Vassilakopoulos TP, et al. Among authors: pangalis ga. Ann Hematol. 2021 Sep;100(9):2279-2292. doi: 10.1007/s00277-021-04421-2. Epub 2021 Feb 1. Ann Hematol. 2021. PMID: 33523289
233 results